Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials: Not "1 and Done".
Sign Up to like & getrecommendations! Published in 2019 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2019.08.010
Abstract: PURPOSE To evaluate panretinal photocoagulation (PRP) treatment and re-treatment patterns in patients with diabetic retinopathy (DR) and diabetic macular edema (DME). DESIGN Post hoc analysis of the phase 3 RIDE (clinicaltrials.gov identifier, NCT00473382) and RISE… read more here.
Keywords: ranibizumab; treatment; prior prp; treated patients ... See more keywords